Su et al. found that pregnancy outcomes after blastocyst transfer varied significantly across BMI categories in PCOS patients receiving ultralong GnRH-a protocols, despite uniform diagnostic criteria and standardised treatment methods [45]. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.